Urology/Gynecology/G.I., Executive Summary

The potential for Uro-gynecological market is mainly due to the enormous increase in burden of uterine pathologies in the last three to four years. The Compound Annual Growth Rate (CAGR) for minimally invasive procedures is consistent at 15-20 percent and this is expected to drive the market and create enormous opportunities for participants.